View in EDS PDF Full Text

Immunosuppressive therapy in multiple sclerosis.

Saved in:
Bibliographic Details
Title: Immunosuppressive therapy in multiple sclerosis.
Authors: Edan, G.
Source: Neurological Sciences. May2005 Supplement 1, Vol. 26, ps18-s18. 1p.
Subjects: Immunosuppressive agents, Multiple sclerosis, Virus diseases, Immunosuppression, Immunoregulation, Neurodegeneration
Abstract: The article informs that there are convincing pathological and epidemiological arguments for the hypothesis that the inflammatory process in multiple sclerosis (MS) is responsible for axonal loss, leading to irreversible deficits. This is a strong argument for using immunosuppressive agents in MS. However, there is also accumulative evidence that the pathogenesis of disability progression is a two-stage disease, involving inflammation and neurodegeneration. Immunosuppressive therapy may have a role in MS, but the timing of such therapy is important.
Database: Psychology and Behavioral Sciences Collection
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 16986901
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immunosuppressive therapy in multiple sclerosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Edan%2C+G%2E%22">Edan, G.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Neurological+Sciences%22">Neurological Sciences</searchLink>. May2005 Supplement 1, Vol. 26, ps18-s18. 1p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Immunosuppressive+agents%22">Immunosuppressive agents</searchLink><br /><searchLink fieldCode="DE" term="%22Multiple+sclerosis%22">Multiple sclerosis</searchLink><br /><searchLink fieldCode="DE" term="%22Virus+diseases%22">Virus diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Immunosuppression%22">Immunosuppression</searchLink><br /><searchLink fieldCode="DE" term="%22Immunoregulation%22">Immunoregulation</searchLink><br /><searchLink fieldCode="DE" term="%22Neurodegeneration%22">Neurodegeneration</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: The article informs that there are convincing pathological and epidemiological arguments for the hypothesis that the inflammatory process in multiple sclerosis (MS) is responsible for axonal loss, leading to irreversible deficits. This is a strong argument for using immunosuppressive agents in MS. However, there is also accumulative evidence that the pathogenesis of disability progression is a two-stage disease, involving inflammation and neurodegeneration. Immunosuppressive therapy may have a role in MS, but the timing of such therapy is important.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=16986901
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10072-005-0393-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: s18
    Subjects:
      – SubjectFull: Immunosuppressive agents
        Type: general
      – SubjectFull: Multiple sclerosis
        Type: general
      – SubjectFull: Virus diseases
        Type: general
      – SubjectFull: Immunosuppression
        Type: general
      – SubjectFull: Immunoregulation
        Type: general
      – SubjectFull: Neurodegeneration
        Type: general
    Titles:
      – TitleFull: Immunosuppressive therapy in multiple sclerosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Edan, G.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 05
              Text: May2005 Supplement 1
              Type: published
              Y: 2005
          Identifiers:
            – Type: issn-print
              Value: 15901874
          Numbering:
            – Type: volume
              Value: 26
          Titles:
            – TitleFull: Neurological Sciences
              Type: main
ResultId 1